Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
submitted by /u/medical_news_mod [link] [comments]
Continue Reading
Month: October 2026
Chargers' Derwin James provides update on pinky injury
Ricardo Sandoval , Chargers Wire Thu, October 1, 2026 at 6:29 AM UTC · 1 min read
Continue Reading
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
Incyte Corp_ office sign-by Bo Shen via iStock Based in Wilmington, Delaware, Incyte Corporation (INCY) is a global biopharmaceutical company that discovers, develops, and commercializes innovative treatments for cancer, blood disorders, and immune-mediated diseases. The company’s marketed therapies include JAKAFI for blood cancer, ICLUSIG for leukemia, PEMAZYRE for bile-duct cancer, MONJUVI/MINJUVI for lymphoma, and NIKTIMVO
Continue Reading